Overview

Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of ADL5859 versus placebo and ADL5747 versus placebo in relieving pain in participants with osteoarthritis of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Collaborator:
Pfizer
Treatments:
Oxycodone